Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Earlier detection is a promising strategy to reduce cancer mortality. For cancers of all stages, therapies are more effective with a lower disease burden. In this study, we demonstrate that ctDNA is detectable 3 years or more before cancer diagnosis and provide estimates for the sensitivity required to achieve such very early detection. See related commentary by Crisafulli et al., p. 1774.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2025-05-22
DOI
https://doi.org/10.1158/2159-8290.cd-25-0375
Citations
11
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
10.30
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Lisa Dobbyn, Samuel D. Curtis, Natalie Silliman, Elizabeth A. Platz et al.
11 citations
Cancer Discovery
Cancer Genomics and Diagnostics
10.30
article

Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Lisa Dobbyn, Samuel D. Curtis, Natalie Silliman, Elizabeth A. Platz, Christopher Douville, Janine Ptak, Nickolas Papadopoulos, Meng Ru, Eric Boerwinkle, Maria Popoli, Josef Coresh, Corinne E. Joshu, Kenneth W. Kinzler, Chetan Bettegowda, Bert Vogelstein, Anna E. Prizment, Yuxuan Wang, Vernon A. Burk
article en
11 citations

Abstract

Earlier detection is a promising strategy to reduce cancer mortality. For cancers of all stages, therapies are more effective with a lower disease burden. In this study, we demonstrate that ctDNA is detectable 3 years or more before cancer diagnosis and provide estimates for the sensitivity required to achieve such very early detection. See related commentary by Crisafulli et al., p. 1774.

Cancer DiscoveryVol. 15(9)
University of Minnesota (US), Howard Hughes Medical Institute (US), Johns Hopkins University (US), Baylor College of Medicine (US), Johns Hopkins Medicine (US), Sidney Kimmel Cancer Center (US), Cancer Genetics (United States) (US), Ludwig Cancer Research (US), Sidney Kimmel Comprehensive Cancer Center (US), New York University (US), The University of Texas Health Science Center at Houston (US)
Good health and well-being
Openalex Percentile: Top 1%
Cancer Genomics and Diagnostics
10.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.